Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Feb 25

PMID 36836874

Authors

Balamurugan Ramatchandirin

Alexia Pearah

Ling He

Affiliations

Soon will be listed here.

Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide is on the rise and NAFLD is becoming the most common cause of chronic liver disease. In the USA, NAFLD affects over 30% of the population, with similar occurrence rates reported from Europe and Asia. This is due to the global increase in obesity and type 2 diabetes mellitus (T2DM) because patients with obesity and T2DM commonly have NAFLD, and patients with NAFLD are often obese and have T2DM with insulin resistance and dyslipidemia as well as hypertriglyceridemia. Excessive accumulation of triglycerides is a hallmark of NAFLD and NAFLD is now recognized as the liver disease component of metabolic syndrome. Liver glucose and lipid metabolisms are intertwined and carbon flux can be used to generate glucose or lipids; therefore, in this review we discuss the important transcription factors and coactivators that regulate glucose and lipid metabolism.

Citing Articles

Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways.

Zhang M, Guo C, Li Z, Cai X, Wen X, Lv F Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458927 PMC: 11514595. DOI: 10.3390/ph17101287.

Identification and characterization of structural variants related to meat quality in pigs using chromosome-level genome assemblies.

Kwon D, Park N, Wy S, Lee D, Park W, Chai H BMC Genomics. 2024; 25(1):299.

PMID: 38515031 PMC: 10956321. DOI: 10.1186/s12864-024-10225-1.

Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.

Al Jadani J, Albadr N, Alshammari G, Almasri S, Alfayez F, Yahya M Nutrients. 2023; 15(22).

PMID: 38004149 PMC: 10675668. DOI: 10.3390/nu15224755.

References

Tai N, Wong F, Wen L . The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord. 2015; 16(1):55-65. PMC: 4348024. DOI: 10.1007/s11154-015-9309-0. View

Knight B, Hebbachi A, Hauton D, Brown A, Wiggins D, Patel D . A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. Biochem J. 2005; 389(Pt 2):413-21. PMC: 1175119. DOI: 10.1042/BJ20041896. View

Bellentani S, Marino M . Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009; 8 Suppl 1:S4-8. View

Dentin R, Tomas-Cobos L, Foufelle F, Leopold J, Girard J, Postic C . Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. J Hepatol. 2011; 56(1):199-209. DOI: 10.1016/j.jhep.2011.07.019. View

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

Ozcan U, Cao Q, Yilmaz E, Lee A, Iwakoshi N, Ozdelen E . Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004; 306(5695):457-61. DOI: 10.1126/science.1103160. View

Jayne S, Zwartjes C, Van Schaik F, Timmers H . Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex. Biochem J. 2006; 398(3):461-7. PMC: 1559471. DOI: 10.1042/BJ20060406. View

Vannucci R, Vannucci S . Hypoglycemic brain injury. Semin Neonatol. 2001; 6(2):147-55. DOI: 10.1053/siny.2001.0044. View

Wu X, Li H, Park E, Chen J . SMRTE inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains. J Biol Chem. 2001; 276(26):24177-85. DOI: 10.1074/jbc.M100412200. View

10.

Wu C, Kang J, Peng L, Li H, Khan S, Hillard C . Enhancing hepatic glycolysis reduces obesity: differential effects on lipogenesis depend on site of glycolytic modulation. Cell Metab. 2005; 2(2):131-40. DOI: 10.1016/j.cmet.2005.07.003. View

11.

Dhiman V, Bolt M, White K . Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis. Nat Rev Genet. 2017; 19(3):160-174. DOI: 10.1038/nrg.2017.102. View

12.

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M . Complications of Diabetes 2017. J Diabetes Res. 2018; 2018:3086167. PMC: 5866895. DOI: 10.1155/2018/3086167. View

13.

Wondisford A, Xiong L, Chang E, Meng S, Meyers D, Li M . Control of Foxo1 gene expression by co-activator P300. J Biol Chem. 2014; 289(7):4326-33. PMC: 3924295. DOI: 10.1074/jbc.M113.540500. View

14.

Chartier F, Bossu J, Laudet V, Fruchart J, LAINE B . Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene. 1994; 147(2):269-72. DOI: 10.1016/0378-1119(94)90079-5. View

15.

Lalmansingh A, Karmakar S, Jin Y, Nagaich A . Multiple modes of chromatin remodeling by Forkhead box proteins. Biochim Biophys Acta. 2012; 1819(7):707-15. DOI: 10.1016/j.bbagrm.2012.02.018. View

16.

Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S . A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature. 2008; 456(7219):269-73. PMC: 2597669. DOI: 10.1038/nature07349. View

17.

Ye J . Improving insulin sensitivity with HDAC inhibitor. Diabetes. 2013; 62(3):685-7. PMC: 3581218. DOI: 10.2337/db12-1354. View

18.

Dif N, Euthine V, Gonnet E, Laville M, Vidal H, Lefai E . Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J. 2006; 400(1):179-88. PMC: 1635455. DOI: 10.1042/BJ20060499. View

19.

Lamichane S, Dahal Lamichane B, Kwon S . Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis. Int J Mol Sci. 2018; 19(4). PMC: 5979443. DOI: 10.3390/ijms19040949. View

20.

Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N . Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. DOI: 10.2337/db07-1403. View